26th Aug 2008 07:00
Sinclair Pharma plc
Disclosure in accordance with Rule 2.10 of the City Code
In accordance with Rule 2.10 of The City Code on Takeovers and Mergers, Sinclair Pharma ("Sinclair Pharma") confirms that as at the close of business on 22 August 2008 its issued share capital consisted of 93,912,674 ordinary shares of 1 pence each.
The ISIN for Sinclair Pharma's ordinary shares is GB0033856740.
Enquiries
For further information please contact:
Sinclair Pharma plc - Tel: +44 (0)1483 410 600
Dr Michael Flynn, CEO
Jerry Randall, CFO
Landsbanki Securities - Tel: +44 (0)20 7426 9000
Shaun Dobson
Claes Spång
Investec - Tel: +44 (0)20 7597 4000
Richard Jones
Patrick Robb
Daniel Adams
Capital MS&L - Tel +44 (0)20 7307 5340
Mary Clark
Anna Mitchell
Related Shares:
Sinclair Pharma